Expertise in
32
conditions

Dr. Mark D. Anderson

Neurology
University Pathology Associates PLLC
2500 N State St, 
Jackson, MS 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Expertise in
32
conditions
University Pathology Associates PLLC
2500 N State St, 
Jackson, MS 

Overview

Mark Anderson is a Neurologist practicing medicine in Jackson, Mississippi.

Dr. Anderson is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.

He is actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 5 clinical trials. Dr. Anderson is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in MS

Hospital Affiliations

University Of Mississippi Med Center
Anderson Regional Medical Center
University Of Mississippi Medical Center- Grenada

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Primewell Health Services
  • HMO
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

University Pathology Associates PLLC
2500 N State St, Jackson, MS 39216

Additional Areas of Focus

Dr. Anderson has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Enrollment Status: Recruiting
Publish Date: July 30, 2026
Intervention Type: Drug, Radiation, Biological
Study Drugs: Temozolomide, Lomustine, Regorafenib, Paxalisib, VAL-083
Study Phase: Phase 2/Phase 3
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Enrollment Status: Recruiting
Publish Date: June 25, 2026
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 3
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
Standard Chemotherapy Versus Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients With Recurrent Glioblastoma Multiforme (GBM).
Standard Chemotherapy Versus Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients With Recurrent Glioblastoma Multiforme (GBM).
Enrollment Status: Completed
Publish Date: April 15, 2025
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

22 Total Publications

Bilateral Parsonage-Turner Syndrome in a Patient With Hemophagocytic Lymphohistiocytosis.
Bilateral Parsonage-Turner Syndrome in a Patient With Hemophagocytic Lymphohistiocytosis.
Journal: Case reports in neurological medicine
Published: February 07, 2025
Similar Doctors
Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required

Office

1030 N Flowood Dr, 
Flowood, MS 
 (4.0 miles away)
601-360-8740
Languages Spoken:
English
See accepted insurances

Patrick Weldon is a Neurologist practicing medicine in Flowood, Mississippi. Dr. Weldon is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Dravet Syndrome, Congenital Mirror Movement Disorder, Serotonin Syndrome, and Transient Ischemic Attack (TIA).

Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

Jackson Neurocare PLLC

971 Lakeland Dr Ste 557, 
Jackson, MS 
 (0.7 miles away)
601-200-4560
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tiffany Scarff is a Neurologist practicing medicine in Jackson, Mississippi. Dr. Scarff is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Stroke, Generalized Tonic-Clonic Seizure, Seizures, and Memory Loss. Dr. Scarff is currently accepting new patients.

Expertise in
24
conditions
Expertise in
24
conditions
Referral may be required

Ruth K. Fredericks M.D.

971 Lakeland Dr, 
Jackson, MS 
 (0.4 miles away)
601-200-4860
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Mchenry is a Neurologist practicing medicine in Jackson, Mississippi. Dr. Mchenry is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Stroke, Essential Tremor, Memory Loss, and Transient Ischemic Attack (TIA). Dr. Mchenry is currently accepting new patients.

Frequently Asked Questions about Dr. Mark D. Anderson

How do I make an appointment with Dr. Mark D. Anderson?

You can book an appointment with Dr. Mark D. Anderson by calling their office at 601-984-5500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark D. Anderson a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark D. Anderson is classified as an Distinguished expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark D. Anderson specialize in?

While Dr. Mark D. Anderson is a Neurology, they have specific expertise in Glioma, Astrocytoma, and Glioblastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Mark D. Anderson participate in research or clinical trials?

Yes. Dr. Mark D. Anderson has published 22 articles and abstracts on conditions like Glioma. You can view a list of Dr. Mark D. Anderson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark D. Anderson accept my insurance?

Dr. Mark D. Anderson accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 601-984-5500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Anderson's expertise for a condition
ConditionClose
    View All 18 Distinguished Conditions
    View All 14 Advanced Conditions
    View All 60 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile